33 studies found for:    " March 20, 2013":" April 19, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" March 20, 2013":" April 19, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (33 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Conditions: HIV;   HIV Infections
Intervention: Drug: E/C/F/TAF
2 Recruiting Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center
Condition: HIV Seropositivity
Interventions: Drug: Placebo;   Drug: Rouvastatin calcium
3 Enrolling by invitation Social Network Intervention to Engage Out-of-Care PLH Into Treatment
Conditions: HIV;   AIDS
Interventions: Behavioral: Social Network Leader Endorsement;   Behavioral: HIV Counseling
4 Recruiting Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Condition: HIV
Interventions: Behavioral: Social Network Intervention;   Behavioral: Counsel, Test, and Treat
5 Recruiting Metabolomics Fingerprinting and Metabolic Dynamis After HIV Infection
Condition: HIV
Intervention:
6 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
7 Completed
Has Results
Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools
Condition: HIV Infection
Intervention:
8 Completed Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Condition: HIV-infection/AIDS
Interventions: Drug: Cenicriviroc;   Drug: Dolutegravir;   Drug: Midazolam
9 Completed Bioequivalence (BE) Study of Individual Atazanavir and Cobicistat Compared to Atazanavir in Fixed Dose Combination With Cobicistat
Condition: Human Immunodeficiency Virus Type 1 (HIV-1)
Interventions: Drug: Atazanavir;   Drug: Cobicistat
10 Active, not recruiting Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
Condition: HIV-associated Enteropathy
Intervention: Other: Serum-derived bovine immunoglobulin protein isolate (SBI)
11 Completed Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts
Condition: QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
Intervention:
12 Not yet recruiting RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients
Condition: Chronic Infection With HIV
Interventions: Drug: Ritonavir boosted Atazanavir;   Drug: Raltegravir;   Drug: TDF/FTC (or 3TC)
13 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
14 Recruiting A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Condition: HIV Infections
Intervention:
15 Recruiting Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Conditions: HIV Infection;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cabozantinib-s-malate;   Other: pharmacological study;   Other: laboratory biomarker analysis
16 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
17 Suspended Lactoferrin Treatment in HIV Patients
Condition: HIV Infection
Interventions: Drug: Recombinant Lactoferrin;   Drug: Placebo
18 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
19 Recruiting Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services
Condition: HIV
Intervention: Behavioral: Conditional cash transfer
20 Active, not recruiting UCLA-Amity Parolee Health Promotion Study
Conditions: Hepatitis B;   Hepatitis C;   HIV;   Drug Addiction
Interventions: Behavioral: Parolee Comprehensive Care + Phone Coach;   Behavioral: Parolee Brief HBV Program + Phone Coach;   Behavioral: Usual Care Group

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years